
Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price Rises 5.28% to Rs 120.65
Updated: 17 Sept 2026 • 3:23 pm
Posted by:

Morepen Laboratories Share Price rose today, with the stock closing at Rs 120.65, up 5.28% from the previous close of Rs 114.60. The company’s market capitalisation stood at Rs 5,822.01 Cr, placing the move in a clear market-cap context for Morepen Laboratories Share Price Today. The session also matters because the data confirms a same-day share price gain, while not establishing a company-specific catalyst. For readers following Morepen Laboratories Stock News, the verified numbers show a stronger day in price terms, a turnover of Rs 14.55 Cr and a trading range between Rs 112.70 and Rs 121.30. Univest is tracking the move as part of its live coverage of Morepen Laboratories Share Price Live, Morepen Laboratories Share Price Update and broader Morepen Laboratories Stock Analysis. What investors can monitor next is whether the share price holds near the day’s higher band and how the stock is valued against healthcare peers.
Morepen Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 120.65 |
| Previous Close | Rs 114.6 |
| Today's Move | Rs 6.05 (+5.28%) |
| Open | Rs 115.3 |
| High | Rs 121.3 |
| Low | Rs 112.7 |
| Turnover | Rs 14.55 crore |
| Market Capitalisation | Rs 5,822.01 crore |
| Market Cap Category | Mid Cap |
Morepen Laboratories Ltd. (MOREPENLAB) rose to Rs 120.65 from the previous close of Rs 114.6, a move of Rs 6.05 or 5.28%. The stock opened at Rs 115.3, reached a high of Rs 121.3, recorded a low of Rs 112.7.
Morepen Laboratories Share Price Today opened at Rs 115.30, moved between Rs 112.70 and Rs 121.30, and settled at Rs 120.65. That leaves the stock Rs 6.05 above the previous close of Rs 114.60, reflecting a 5.28% rise for the day. The move also places the close near the session high, which is useful context for Morepen Laboratories Share Price News and Morepen Laboratories Share News. On a market-cap basis, the company ended the session at Rs 5,822.01 Cr, with turnover of Rs 14.55 Cr. Univest is presenting the event as a verified price rise, not as a company-event story with an unconfirmed catalyst.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,822.01 crore |
| P/E Ratio | 44.69x |
| P/B Ratio | 4.82x |
| ROE | 7.96% |
| ROCE | 10.19% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.17% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 44.69x, P/B 4.82x, ROE 7.96%, ROCE 10.19%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 5822.01 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.69x, P/B at 4.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 44.69x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 4.82x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 7.96% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 10.19% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 5,822.01 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 44.69x, which is above the benchmark median of 31.35x, a difference of +42.55%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.78%, a difference of -32.43%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.65%, a difference of -25.35%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 44.69x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.96% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 5,822.01 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- Morepen Laboratories Share Price rose 5.28% today to Rs 120.65 after closing above the previous close of Rs 114.60.
- The day’s range was Rs 112.70 to Rs 121.30, and the close finished near the upper end of that band.
- Market capitalisation stood at Rs 5,822.01 Cr, which gives Morepen Laboratories Share Price Today a defined size context.
- P/E at 44.69 and P/B at 4.82 place the stock above the sector median on both valuation measures.
- EPS of Rs 2.56, book value of Rs 23.78 and dividend yield of 0.17% add core fundamental context for Morepen Laboratories Stock News.
About Morepen Laboratories
Morepen Laboratories Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s public market profile, as reflected in Morepen Laboratories Share Price, is shaped by its market capitalisation of Rs 5,822.01 Cr and the financial ratios supplied for this note. Morepen Laboratories Stock News is often followed through valuation, profitability and market-cap context because those are the verified data points available in the record.
The company description supplied in the data set is limited, so the most reliable way to understand the business is through its listed-market metrics and sector placement. The stock sits inside a large same-industry benchmark universe of 200 companies, which makes Morepen Laboratories Share Price Today relevant for readers who want a measured view of where the company stands within Indian pharmaceuticals. For Morepen Laboratories Latest News, Univest focuses on factual updates, peer comparison and company financials.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Morepen Laboratories Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Morepen Laboratories Share Price Today, Morepen Laboratories Stock Analysis, Morepen Laboratories Fundamental Analysis and sector context in one place for easy review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Morepen Laboratories Share Price rise today?
Ans. The data confirms that Morepen Laboratories Share Price rose 5.28% to Rs 120.65, but it does not establish a company-specific catalyst. The move is still meaningful because it came with a defined intraday range and a higher close.
What is Morepen Laboratories Share Price Today?
Ans. Morepen Laboratories Share Price Today is Rs 120.65. That is Rs 6.05 above the previous close of Rs 114.60 and reflects a same-day gain of 5.28% in the market session.
What is Morepen Laboratories market capitalisation?
Ans. Morepen Laboratories market capitalisation stands at Rs 5,822.01 Cr. This places the company well above the benchmark median for the same-industry set, though market cap indicates size rather than quality.
How does Morepen Laboratories compare with pharma peers?
Ans. Morepen Laboratories has a P/E of 44.69 and P/B of 4.82, which sit between lower-valued peers such as Cipla and Zydus Lifesciences and higher-valued names such as Divi's Laboratories and Torrent Pharmaceuticals.
What do Morepen Laboratories EPS and book value show?
Ans. Morepen Laboratories EPS is Rs 2.56 and book value is Rs 23.78. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share at the current point in time.
Is Morepen Laboratories valuation above the sector median?
Ans. Yes, Morepen Laboratories trades above the same-industry median on both P/E and P/B. Its P/E is 44.69 versus a median of 31.35, while its P/B is 4.82 versus a median of 2.98.
What is Morepen Laboratories dividend yield?
Ans. Morepen Laboratories dividend yield is 0.17%. Dividend yield is a historical or current income measure, so it should be read alongside the company’s valuation, earnings base and peer positioning rather than in isolation.
Where can I track Morepen Laboratories Share Price live?
Ans. You can track Morepen Laboratories Share Price live on Univest, where the stock page brings together price updates, fundamental ratios, sector context and peer comparison in a single place for easier review.
Recent Articles

Welspun Living Ltd. (WELSPUNLIV): Welspun Living Share Price rises 5.10% today; stock news in focus
17 September 2026

Paradeep Phosphates Ltd. (PARADEEP): Paradeep Phosphates Share Price Rises 5.18% as Stock Gains Today
17 September 2026

MILLWORKS TECHNOLOGIES LIMITED (MILLWORKS) Share Price Rises 8.13% as Stock News Focuses on Rs 1,200 Level
17 September 2026

Rappid Valves (India) Ltd. Hits Upper Circuit on NSE, 17 September 2026
17 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Welspun Living Ltd. (WELSPUNLIV): Welspun Living Share Price rises 5.10% today; stock news in focus
Paradeep Phosphates Ltd. (PARADEEP): Paradeep Phosphates Share Price Rises 5.18% as Stock Gains Today
MILLWORKS TECHNOLOGIES LIMITED (MILLWORKS) Share Price Rises 8.13% as Stock News Focuses on Rs 1,200 Level
Rappid Valves (India) Ltd. Hits Upper Circuit on NSE, 17 September 2026
Suryalakshmi Cotton Mills Ltd. (SURYALAXMI): Suryalakshmi Cotton Mills Share Price rises 8.83% as stock gains today

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





